Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Submitted by
admin
on February 10, 2016 - 3:20pm
Source:
Fierce Pharma Marketing
News Tags:
PCSK9 inhibitors
heart failure
Praluent
Repatha
Novartis
Amgen
Sanofi
Regeneron
Headline:
Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Do Not Allow Advertisers to Use My Personal information
